Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study
Caryn S. Ross-Innes(University of Cambridge), Peter Sasieni(Queen Mary University of London), Anjan Dhar(Unknown), Richard Ostler, Bernard V. North, Benoit Aigret, S M Griffin(Unknown), Laurence Lovat(University College London), Adam Haycock(St Mark's Hospital), Rebecca C. Fitzgerald(Cancer Research UK), Matthew D. Rutter(North Tees and Hartlepool NHS Foundation Trust), Sybil Varghese(MRC Cancer Unit), Sarmed S. Sami(Queen's Medical Centre), Philip Kaye(Nottingham University Hospitals NHS Trust), Stephen Attwood, Rehan Haidry(University College Hospital), Irene Debiram–Beecham(MRC Cancer Unit), Pradeep Bhandari(Queen Alexandra Hospital), Pierre Lao-Sirieix(MRC Cancer Unit), Krish Ragunath(Nottingham University Hospitals NHS Trust), Danielle Morris(Lister Hospital), Elaine Walker(MRC Cancer Unit), Babett Disep(Royal Victoria Infirmary), Marco Novelli(University College Hospital), Colin Rees(Durham University), Maria O’Donovan(Addenbrooke's Hospital)
Cited by 301
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
|New England Journal of Medicine|2019|1.5k
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
|Gut|2013|1.3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k